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Regulatory CD4 T cells (T reg cells), which are 
characterized by expression of Foxp3, are major 
contributors to the antiinflammatory response 
in the settings of autoimmune disease, cancer, and 
infections (Vignali et al., 2008). In infectious 
settings, they help to resolve the proinflamma-
tory response, thereby minimizing bystander 
damage but also potentially delaying or pre-
venting pathogen clearance (Belkaid, 2007). T reg 
cells may also be required for efficient immune 
cell entry into sites of infection (Lund et al., 
2008). Pathogen-specific T reg cells have been 
detected in a few studies using whole pathogen 
preparations as targets, without identification of 
specific target epitopes. In mice infected with 
Leishmania major or Toxoplasma gondii, parasite-
specific T reg cells were demonstrated, but the 
target antigen or epitope was not further iden-
tified  (Suffia  et  al.,  2006;  Oldenhove  et  al., 
2009). In another study, T reg cells specific for 
a Mycobacteria tuberculosis epitope (Mtb) were 
studied using Mtb-specific TCR Tg cells, but 
T reg cells specific for this epitope were not found 
in the natural infection and no Mtb-specific   
T reg cell target epitope has thus far been iden-
tified (Shafiani et al., 2010). Identification of 
pathogen-specific epitopes recognized by T reg 
cells would facilitate their study and therapeutic 
use in disease settings.
The neurotropic rJ2.2 strain of mouse hepa-
titis virus, a coronavirus, causes mild acute enceph-
alitis and chronic demyelination (Fleming et al.,   
1986). We previously showed that T reg cells have 
a critical role in diminishing immunopathological 
disease  in  rJ2.2-infected  mice.  Thus,  adoptive 
transfer of T reg cells from naive spleens (natural 
T reg cells) into infected mice decreased weight 
loss, clinical scores, and demyelination (Trandem 
et al., 2010). However, whether any of these T reg 
cells are virus specific and whether virus-specific 
T reg cells are immunosuppressive in a cognate 
epitope-dependent manner are not known.
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Foxp3+ CD4 regulatory T cells (T reg cells) are important in limiting immunopathology in 
infections. However, identifying pathogen-specific epitopes targeted by these cells has been 
elusive. Using MHC class II/peptide tetramers and intracellular cytokine staining, we iden-
tify T reg cells recognizing two virus-specific CD4 T cell epitopes in the coronavirus-
infected central nervous system as well as naive T cell precursor pools. These T reg cells are 
detected at the same time as effector T cells (T eff cells) exhibiting the same specificity 
and can suppress T eff cell proliferation after stimulation with cognate peptide. These 
virus-specific T reg cells may be especially effective in inhibiting the immune response 
during the peak of infection, when virus antigen is maximal. Furthermore, these T reg cells 
express both IL-10 and IFN- after peptide stimulation. IFN- expression is maintained 
during both acute and chronic phases of infection. Identification of T reg cell target epi-
topes by cytokine production is also applicable in autoimmune disease because myelin 
oligodendrocyte glycoprotein–specific Foxp3+ T reg cells express IL-10 and IL-17 at the 
peak of disease in mice with experimental autoimmune encephalomyelitis. These results 
show that pathogen epitope-specific Foxp3+ T reg cells can be identified on the basis of 
cytokine production.
© 2011 Zhao et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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time that virus-specific effector CD4 T cells could be identi-
fied (Haring et al., 2001), and were present at approximately 
the same frequency in both the acute and chronic stages of 
the infection (Fig. 2, C and D). In addition, after stimulation 
with anti-CD3 mAb, the fraction of T reg cells expressing 
IFN- increased two- to fourfold, suggesting that M133 + 
S358–specific T reg cells accounted for only a fraction of all 
IFN-+ T reg cells in the CNS (Fig. 2, B–D). Notably, the 
mean fluorescence intensity of IFN- expression was lower in 
M133 + S358–specific T reg cells compared with effector CD4 
T cells, indicating less expression on a per-cell basis (Fig. 2 F). To 
verify that T reg cells produce IFN- in vivo, we treated B6 
mice with brefeldin A (BFA) at 6 d after infection (Fig. 2 E; 
Liu and Whitton, 2005). In the absence of BFA, some Foxp3 
CD4 T cells were IFN-+, consistent with results showing 
that cells in the infected brain express IFN- in the absence 
of ex vivo stimulation (Fig. 2 A). The frequency of Foxp3 
and Foxp3+ cells expressing IFN- increased twofold and 
In this paper, we identify two epitopes (M133 and S358) 
targeted by T reg cells in the rJ2.2-infected central nervous 
system (CNS). Both epitopes are also recognized by effector 
T  cells  (Haring  et  al.,  2001). These  virus  epitope-specific   
T reg cells express both IL-10 and IFN-, suppress proliferation 
of virus-specific effector cells after stimulation with cognate 
peptide, and are present throughout the acute and resolution 
phases of the infection. Virus-specific T reg cells appear to 
arise, at least in part, from natural T reg cell pools because they 
are detected in naive Foxp3gfp mice and mice retrogenic (Rg) 
for an M133-specific T cell receptor (TCR) and express the 
transcription factor helios.
RESULTS AND DISCUSSION
Virus-specific effector CD4 T cells and T reg cells are detected 
at the same time after infection in the brains  
of rJ2.2-infected mice
Foxp3gfp mice were infected with rJ2.2 and examined for the 
presence of Foxp3+ T reg cells. The frequency of Foxp3+ T reg 
cells was 20–30% at 3 and 5 d after infection, decreasing to 
<10% of total CD4 T cells in the brain and spinal cord by   
7 d after infection (Fig. 1 A). The decrease in frequency by 
day 7 did not reflect a lower rate of proliferation because similar 
fractions of T reg cells and non–T reg CD4 T cells incorpo-
rated BrdU at 6 d after infection (Fig. 1 B). Rather, it likely 
reflects recruitment of virus-nonspecific T reg cells into the 
CNS at early stages of the infection.
We previously showed that virus-specific effector CD4 
and CD8 T cells were detected in the infected brain at 6–7 d 
after infection (Haring et al., 2001). MHC class II/peptide 
tetramers are available for detecting epitope M133-specific 
CD4 T  cells,  and  using  these  tetramers,  we  also  detected 
M133-specific T reg cells in the brain and spinal cord at 7 d 
after infection (Fig. 1, C and E). Furthermore, M133-specific 
T reg cells were present in the infected CNS until at least 49 d 
after infection. M133-specific T reg cells were not routinely 
detected above background in draining cervical LNs (CLNs) 
or spleen (unpublished data). Staining with M133 tetramer 
was specific because no positive cells were detected in mice 
infected with an rJ2.2 variant in which the epitope was mu-
tated, abrogating recognition (rJ.2.2.MY135Q; Fig. 1 D; Anghelina 
et al., 2006).
rJ2.2-specific T reg cells express IFN-g and IL-10
To further characterize these virus-specific T reg cells, we 
next assessed whether they produced cytokines in response to 
peptide stimulation. Remarkably, 4–6% of all CNS (pooled 
brain and spinal cord)-derived T reg cells expressed IFN-, 
after peptide M133 stimulation at 14 d after infection (Fig. 2 A). 
We also identified IFN-+ T reg cells specific for a second 
rJ2.2-specific CD4 T cell epitope, S358 in the CNS. In ex-
periments described later in this paper, cells were stimulated 
with M133 and S358 peptides together (M133 + S358) be-
cause virus-specific T reg cells were present in low numbers 
in the infected CNS (Fig. 2 B). Virus-specific IFN-+ T reg 
cells were detected as early as 6 d after infection, at the same 
Figure 1.  Identification of epitope M133-specific T reg cells  
using MHC class II tetramer. (A) CNS-derived lymphocytes from rJ2.2-
infected Foxp3gfp mice were analyzed for Foxp3+ CD4 T cells at the indi-
cated times after infection (n = 5 mice for each time point, in at least 
two independent experiments). (B) BrdU incorporation by CNS-derived 
CD4 T cells at 6 d after infection is shown. Data shown are representative 
of six mice analyzed in three independent experiments. (C and D) Foxp3gfp 
mice were infected with rJ2.2 (C) or rJ2.2.MY135Q (D) and sacrificed at the 
indicated times after infection. Brain and spinal cord (SC)–derived lym-
phocytes were stained with I-Ab/M133 tetramers and representative 
plots gated on CD4+ T cells are shown. (E) Frequency of T reg cells that 
are I-Ab/M133 tetramer-positive is shown. Data are from four to seven 
mice per time point in two to five independent experiments. Error bars in 
A and E indicate mean ± SEM.JEM Vol. 208, No. 8  1573
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fivefold, respectively, after in vivo BFA treatment, confirming 
in situ IFN- expression by T reg cells. Consistent with the 
in vitro peptide stimulation analyses, the mean fluorescence in-
tensity of IFN- expression was lower in T reg cells compared 
with effector CD4 T cells after in vivo BFA treatment (Fig. 2 F).
A majority of these virus-specific IFN-+ T reg cells ex-
pressed TNF but virtually none expressed IL-2 (Fig. 3, A and B). 
IL-10 production by T reg cells has been previously docu-
mented (Vignali et al., 2008) and as shown in Fig. 3 (C and D), 
50% of IFN-+ T reg cells also expressed IL-10. Addition-
ally, a substantial percentage only produced IL-10. T reg cells 
at sites of Th1-type inflammation express the transcription 
factor T-bet (Koch et al., 2009). Consistent with the proinflam-
matory nature of the rJ2.2-infected brain, 35% of all T reg cells 
also expressed this protein (Fig. S1, A and B). All IFN-+ M133 + 
S358–specific T reg cells were T-bet positive (Fig. S1 C).
These assays all used Foxp3gfp mice to detect virus epitope-
specific T reg cells. Next, we confirmed concordant label-
ing of GFP and Foxp3 detected with anti-Foxp3 antibody in 
both naive CLNs and infected brains (Fig. S2 A). To show that 
IFN- virus-specific T reg cells were also detected in WT 
mice, we infected B6 mice with rJ2.2 and analyzed CNS-
derived cells at 7 d after infection. A similar percentage of 
M133 + S358–specific T reg cells expressed IFN- as was 
detected in infected Foxp3gfp mice (Fig. S2 B).
M133-specific T reg cells suppress proliferation of cognate 
epitope-specific effector CD4 T cells
To  determine  whether  M133-specific T  reg  cells  were   
immunosuppressive, we isolated GFP+ and GFP CD4 T cells 
Figure 2.  Expression of IFN- by rJ2.2-specific T reg cells. (A–D) rJ2.2-infected Foxp3gfp mice were sacrificed at the indicated times after infection 
and CNS-derived lymphocytes analyzed for IFN- production after peptide stimulation. Representative experiments for 14 d after infection are shown in 
A and B. (A) M133- and S358-specific T reg cells express IFN-. Stimulation with lymphocytic choriomeningitis virus GP61 or no peptide served as con-
trols. (B) T reg cells express IFN- after stimulation with M133 + S358 peptides or anti-CD3 mAb. Numbers in parentheses represent percentage of IFN-+ 
T reg cells. (C and D) Mean frequency (C) and number (D) of T reg cells that express IFN- after stimulation with peptides M133 + S358 or anti-CD3 mAb. 
Data shown are representative of 3–20 single or pooled brain samples per time point in 3–10 independent experiments. (E) rJ2.2-infected B6 mice were 
treated with BFA or vehicle at 6 d after infection. After 6 h, CNS-derived lymphocytes were analyzed for IFN- expression. Plots shown were gated on 
CD4 T cells. Data are representative of six mice in two independent experiments. 5.1 ± 0.5 and 4.6 ± 0.3% of Foxp3 and Foxp3+ cells, respectively,  
expressed IFN- after in vivo BFA treatment. (F) IFN- is expressed at higher levels in effector CD4 T cells than in T reg cells after peptide M133 + S358 
stimulation (data from 10 single or pooled brain samples analyzed at 7, 14, or 28 d after infection are combined) or after in vivo BFA treatment (six mice 
in two independent experiments). MFI, mean fluorescence intensity. Error bars in C, D, and F indicate mean ± SEM.
Figure 3.  Expression of TNF and IL-10, but not IL-2, by rJ2.2-
specific T reg cells. CNS-derived lymphocytes were pooled from rJ2.2-
infected Foxp3gfp mice at 14 d after infection and analyzed for IFN-, TNF, 
IL-10, and IL-2 production after peptide stimulation. Cells were gated on 
GFP (T eff) or GFP+ (T reg) CD4 T cells. (A and B) A majority of IFN- 
–expressing M133 + S358–specific T reg cells also produced TNF but none 
expressed IL-2. (C and D) Dual expression of IL-10 and IFN- by M133 + 
S358–specific T reg cells was detected. (A, B, and D) Pooled data from 6–10 
pooled brain samples analyzed in three to five independent experiments 
are shown. Error bars indicate mean ± SEM.1574 Virus-specific IFN-+ and IL-10+Foxp3+ T reg cells | Zhao et al.
ramers, we detected 163 ± 10 Foxp3 and 25 ± 2 Foxp3+ 
M133-specific CD4 T cells per three naive Foxp3gfp mice (n = 3; 
Fig. 5 A). To confirm these results in mice with a higher 
M133-specific precursor frequency, we developed Rg mice 
expressing an M133-specific T cell receptor, as described in 
Materials and methods (M133 TCR Rg). 0.2–5% of splenic 
CD4 T cells were M133 specific in uninfected M133 TCR 
Rg mice and, of these cells, 0.5–1% were Foxp3+ (Fig. 5 C). 
To  determine  whether  IFN-+  M133-specific T  reg  cells 
were detectable in infected M133 TCR Rg mice, we infected 
mice that contained <1% Rg CD4 T cells with rJ2.2. The fre-
quency of M133-specific CD4 T cells as assessed by IFN- 
expression (Fig. 5 B) was modestly higher than in B6 mice 
(Fig. 2 A; Zhao et al., 2009), but most of the cells were M133 
Rg cells. A small fraction of these cells were Foxp3+ and most 
expressed IFN- after M133 peptide stimulation (Fig. 5 D).
To further investigate whether these T reg cells were de-
rived from natural T reg cells, we measured expression of the 
helios, a transcription factor. Helios has been reported to be 
expressed by natural but not peripherally converted T reg 
cells (Thornton et al., 2010). Some M133 + S358–specific 
IFN-+ T reg cells in the infected brain expressed high level 
of helios, consistent with an origin in natural T reg cell popu-
lations (Fig. S4). However, many of the IFN-+ cells were 
helios intermediate, making it uncertain as to whether all of 
these cells were thymically derived.
IL-10+ and IL-17+ myelin oligodendrocyte glycoprotein 
(MOG)35-55–specific T reg cells are present in the brains of 
mice with experimental autoimmune encephalomyelitis (EAE)
Our results from rJ2.2-infected mice showed that virus-specific 
T reg cells expressed IFN- and IL-10 in the inflamed brain. To 
determine whether this was also true in autoimmune settings, we 
examined cytokine production by MOG35-55-specific T reg cells 
in Foxp3gfp mice with EAE (Fig. S5). In these mice, 12 and 32% 
CD4 T cells in the inflamed brain were Foxp3+ at 15 and 32 d 
after immunization, respectively (Fig. S5 C). To determine 
whether these T reg cells expressed cytokines in response to pep-
tide stimulation, we exposed cells directly ex vivo to MOG35-55 
and measured IL-10, IFN-, and IL-17 production. IL-10 was 
expressed by the majority of cytokine-producing MOG35-55-
specific T reg cells, whereas small percentages expressed IL-17 
(Fig. S5 D) at day 15. By day 32, only a small fraction of T reg 
cells expressed either of these cytokines (Fig. S5 E).
Identification of T reg cell–specific target epitopes in 
infected nontransgenic animals has proven difficult. Our results 
demonstrate the presence of virus-specific Foxp3+ T reg cells 
in the rJ2.2-infected CNS but also show that they are present 
at a low frequency (Figs. 1 and 2). Detection was initially   
facilitated by the availability of M133-specific MHC class II 
tetramers. However, we previously showed that this tetramer 
was  not  as  efficient  as  cytokine  expression  in  identifying 
M133-specific effector CD4 T cells (Zhao et al., 2009). Sub-
sequently, we identified a greater frequency of M133-specific 
T reg cells by cytokine staining for IL-10 and IFN- after 
peptide stimulation. IL-10 expression may be particularly 
from the brains of rJ2.2-infected Foxp3gfp mice at day 7 after 
infection and used them in direct ex vivo suppression assays. 
As a control, we isolated GFP+ T reg cells from mice infected 
with rJ2.2.MY135Q, which does not express epitope M133. As 
shown in Fig. 4 A, T reg cells harvested from rJ2.2, but not 
from rJ2.2.MY135Q-infected mice, suppressed proliferation of 
brain-derived effector T cells after M133 peptide stimulation. 
In contrast, T reg cells from brains infected with either virus 
were suppressive after stimulation with anti-CD3 (Fig. 4 B). 
To determine the relative suppressive ability of brain-derived 
T reg cells, we compared them to T reg cells isolated from naive 
spleens in proliferation assays as described in Materials and 
methods. In these assays, responder cells were harvested from 
uninfected spleens and stimulated with anti-CD3 mAb. The 
brain-derived T reg cells were more suppressive than splenic 
T reg cells (Fig. 4 C), possibly because T reg cells from sites of 
inflammation are more activated than those derived from 
naive mice. Consistent with this, brain-derived T reg cells ex-
pressed higher levels of CD69, ICOS, and CTLA-4 directly 
ex vivo and of IL-10 after stimulation with anti-CD3 anti-
body or PMA and ionomycin (Fig. S3).
M133-specific T reg cells are detected in naive  
M133-specific CD4 T cell populations and express helios
 Detection of M133-specific effector CD4 T cells and T reg 
cells at 6 d after infection was consistent with the notion that 
M133-specific T reg cells were present in the natural T reg 
cell pool. To address this, we used MHC/peptide tetramers 
and magnetic bead technology, which facilitates the identifi-
cation  of  epitope-specific  precursor T  cells  in  naive  mice 
(Moon et al., 2009). Using this approach and I-Ab/M133 tet-
Figure 4.  Suppression mediated by M133-specific T reg cells.  
(A and B) Foxp3gfp mice were infected with rJ2.2 or rJ2.2.MY135Q. GFP+  
(T reg cell) and GFP (responder, only from rJ2.2-infected mice) CD4 T cells 
were isolated from infected brains at 7 d after infection and used in T cell 
proliferation assays. (A) T reg cells from rJ2.2 but not rJ2.2.MY135Q-infected 
mice suppressed proliferation of responder cells after peptide M133 stim-
ulation. (B) T reg cells from both rJ2.2 or rJ2.2.MY135Q-infected mice sup-
pressed proliferation of responder cells after anti-CD3 mAb stimulation. 
Data in A and B are representative of three independent experiments, 
with cells pooled from 5–10 mice/group in each experiment. (C) T reg cells 
harvested from rJ2.2-infected brains (pools of 10 mice) or naive spleens 
were used in T cell proliferation assays with CFSE-labeled naive splenic 
CD4 T cells as responders. Cells were stimulated with anti-CD3 mAb. The 
percentage of suppression by T reg cells is shown. **, P < 0.01; *, P < 0.05. 
P = 0.08 at 1:4. Data from three pooled brain samples or naive spleens in 
three individual experiments are shown. Error bars indicate mean ± SEM.JEM Vol. 208, No. 8  1575
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Our results suggest that rJ2.2-specific T reg cells originate, 
at least in part, from natural T reg cell populations. First, virus-
specific T reg cells are detected at 6–7 d after infection at the 
same time as effector CD4 T cells. If these cells arose by pe-
ripheral conversion from effector cells, this process would 
need to occur concomitantly with priming. Second, M133-
specific T reg cells can be detected in the spleens and LNs of 
naive Foxp3gfp and Rg M133 TCR mice (Fig. 5), showing that 
they are present in the naive T reg cell pool. Third, some 
M133 + S358–specific T reg cells expressed high levels of 
helios, a transcription factor expressed by thymus-derived but 
not induced T reg cells (Fig. S4; Thornton et al., 2010).
In summary, we demonstrate the presence of IFN-– and 
IL-10–expressing virus-specific T reg cells in the CNS of in-
fected mice and show that these T cells suppress proliferation 
of cognate epitope-specific CD4 T cells. Detection of epitope-
specific T reg cells by cytokine expression may be especially 
useful because MHC class II/peptide tetramers are not widely 
available and may detect only high-affinity cells (Sabatino et al., 
2011). In addition, previous efforts using T reg cells therapeu-
tically to diminish excessive inflammatory responses have 
used adoptive transfer of in vitro propagated T reg cells (Tang 
et al., 2004; Tarbell et al., 2004). Identification of virus-specific 
T reg cells raises the possibility that an alternative thera-
peutic approach will be to augment expansion of T reg   
cells specific for a virus or pathogenic self epitope at sites   
of inflammation.
MATERIALS AND METHODS
Mice. Specific pathogen-free 6-wk-old C57BL/6 mice (B6) were purchased 
from the National Cancer Institute (Bethesda, MD). Foxp3gfp mice on a B6 
background were provided by A. Rudensky (University of Washington, 
Seattle, WA). OT-II mice, transgenic for expression of a TCR specific for epi-
tope OVA323-339, were obtained from T. Griffith (University of Iowa, Iowa 
City, IA). All animal studies were approved by the University of Iowa Animal 
Care and Use Committee.
For M133 TCR Rg mice, to identify M133-specific T cell receptors, 
splenocytes were harvested 7 d after infection from mice infected i.p. with 
the neurovirulent JHM strain of mouse hepatitis virus and were stimulated 
with 5 µM of peptide M133. After stimulation, epitope-specific CD4 T cells 
useful for detecting epitope-specific T reg cells because IL-10 
was produced in virally infected mice and in mice with EAE 
after peptide stimulation (Fig. 3 and Fig. S5). IFN- produc-
tion by T reg cells was previously demonstrated in a lethal 
toxoplasmosis  infection  (Oldenhove  et  al.,  2009),  but  our   
results indicate that IFN- is also expressed in the context of a 
nonlethal viral infection and continues even as the inflamma-
tory response subsides (Fig. 2). The continued expression of 
IFN- by virus-specific T reg cells likely occurs because virus 
antigen persists in the infected CNS (Bergmann et al., 2006; 
Zhao et al., 2009). Epitope M133-specific T reg cells sup-
pressed proliferation of effector CD4 T cells responding to 
the same epitope, suggesting that if IFN- expression dimin-
ishes T reg cell suppressive function, its effect is limited. rJ2.2-
specific T reg cells were detected in the CNS and not draining 
CLNs or spleen (Fig. 1 and not depicted), suggesting that they 
function by directly inhibiting T cell function or diminishing 
antigen presentation by microglia or other antigen-presenting 
cells at the site of inflammation.
Do virus-specific T reg cells generally play a critical role 
in diminishing immunopathology? In several infectious dis-
eases, including patients infected with West Nile virus or 
Dengue fever virus, higher T reg cell frequencies correlated 
with improved outcomes (Lühn et al., 2007; Lanteri et al., 
2009). Relevant for our results, Mtb-specific TCR Tg T reg 
cells were more potently suppressive than Mtb-nonspecific 
TCR Tg T reg cells in infected mice (Shafiani et al., 2010). 
Furthermore, although transfer of natural T reg cells dimin-
ished disease in the setting of autoimmune disease, suppression 
was estimated to be 20–50-fold more potent if T reg cells 
were specific for an epitope at a site of inflammation (Tang 
et al., 2004; Tarbell et al., 2004). Thus, islet-specific T reg cells 
prevented diabetes in NOD mice, whereas nonspecific T reg 
cells at the same dosage could not. If true for rJ2.2-specific   
T reg cells, these cells may be especially potent in diminishing 
immunopathology in mice with encephalomyelitis and would 
be most activated and, thereby, suppressive during acute infec-
tion when viral antigen is maximal (Bergmann et al., 2006).
Figure 5.  Detection of M133-specific  
T reg cells in naive Foxp3gfp and M133 TCR 
Rg mice. (A) Lymphocytes were pooled from 
the spleens and LNs of three naive Foxp3gfp or 
two OT-II mice and analyzed for tetramer 
M133–positive T reg cells. Numbers of Foxp3 
and Foxp3+ M133-specific CD4 T cells/3 mice 
are indicated. Representative data from one 
of three independent experiments are shown. 
(B–D) M133 TCR Rg mice were infected with 
rJ2.2 and sacrificed at 7 d after infection  
(B and D) or were not infected (C). (B) M133-
specific (GFP+) CD4 T cells accumulated in the 
infected brain and expressed IFN- after 
M133 peptide stimulation. (C) GFP+ CD4  
T cells from spleens of uninfected mice were 
analyzed for Foxp3 expression. (D) Lymphocytes from the brains of rJ2.2-infected mice were stimulated with peptide M133 and assayed for Foxp3 and 
IFN- expression after gating on GFP+ CD4 T cells. Numbers in parentheses represent percentage of IFN-+ T reg cells. Data shown in B–D are representa-
tive of two independent experiments containing three mice each.1576 Virus-specific IFN-+ and IL-10+Foxp3+ T reg cells | Zhao et al.
Intracellular  cytokine  staining. To  detect  cytokine  production  by   
antigen-specific CD4+ effector T cells (T eff cells) and T reg cells, mononuclear 
cells isolated from the brain and spinal cord were stimulated with 5 µM of 
peptides M133, S358, M133 + S358 (rJ2.2 infection), or MOG35-55 (in EAE) 
in complete RPMI 1640 medium for 6 h at 37°C, in the presence of 1 µl/ml 
Golgiplug (BD) and antigen-presenting cells (CHB3 cells, B cell line, H-2Db, 
I-Ab). The rJ2.2-specific epitopes encompass residues 133–147 of the trans-
membrane (M) protein and residues 358–372 of the surface (S) glycoprotein 
(Xue and Perlman, 1997; Haring et al., 2001). Intracellular expression of 
IFN-, IL-10, TNF, IL-2, or IL-17 was assayed. For some samples, cells were 
pooled from two to four mice. In some experiments, infected mice were 
treated with 0.25 mg BFA (Sigma-Aldrich) or vehicle (5% DMSO) intra-
venously. 6 h later, CNS-derived lymphocytes were analyzed directly ex vivo 
for IFN- expression as described previously (Liu and Whitton, 2005). Only 
infected mice were analyzed because virtually no T cells are detected in the 
uninfected brain.
In vitro suppression assay. CD4+ T cells were enriched by negative mag-
netic selection from rJ2.2- or rJ2.2.MY135Q-infected brains (pooled from 10 
mice) or naive spleens of Foxp3gfp mice using a CD4+ T cell isolation kit and 
AutoMACS (both from Miltenyi Biotec) or a mouse CD4+ T cell enrich-
ment kit and Purple EasySep Magnet (both from STEMCELL Technolo-
gies). After  enrichment  of  CD4+ T  cells,  CD4+GFP  responder  and 
CD4+GFP+ regulatory T cells were then sorted using a FACSDiva or FACSAria 
cell sorter (BD). For the suppression assay, 3 × 104 CFSE-labeled (2.5 µM;   
Invitrogen) responder T cells from rJ2.2-infected brains or naive spleens were 
co-cultured with the indicated number of T reg cells and 105 irradiated CHB3 
cells (2,500 rad) per well, in the presence of 5 µM M133 peptide or 1 µg/ml 
anti-CD3 mAb in a 96-well round bottom plate. After 66 h, cells were har-
vested and stained with anti–CD4-PE and anti–Foxp3–Alexa Fluor 647. 
CD4+Foxp3 responder cells were analyzed for CFSE dilution by flow cyto-
metry. The division index (DI) was obtained using FlowJo software (Tree Star). 
The percentage of suppression by T reg cells was calculated as follows: % suppres-
sion = 100% × [1  (DI of responders plus T reg cells/DI of responders only)].
Detection of M133-specific T reg cells in naive T cell pool. M133-
specific T reg cells in the naive T cell pool were identified using a previously 
described method (Moon et al., 2009) with modifications. In brief, single cell 
suspensions were prepared from spleens and cervical, axillary, brachial ingui-
nal, and mesenteric LNs of uninfected 10-wk Foxp3gfp and OT-II mice. CD4 
T cells were isolated by negative selection using a CD4 T cell isolation kit II. 
CD4 T cells were then stained with anti-CD16/32 mAb (2.4G2) and PE-
conjugated I-Ab/M133 tetramers as described in the previous section (except 
tetramer was used at 4 µg/ml to reduce background). After washing, cells 
were exposed to anti-PE magnetic microbeads and separated on an MS col-
umn (Miltenyi Biotec). Cells were then stained with anti–CD3-PerCP, anti–
CD4-Alexa  Fluor  700,  and  non–T  cell  lineage  (dump)  markers  (eFluor 
450–conjugated anti-CD11b, anti-CD11c, anti-F4/80, anti-B220, and anti-
CD49b). Cells were then stained with Hoechst 33258 to gate out dead cells, 
and analyzed with a LSRII cytometer (BD).
Induction of EAE. EAE was induced in Foxp3gfp mice using a previously 
described method (Wang et al., 2006). In brief, mice were immunized with 
0.4 ml of an emulsion containing 300 µg MOG35-55 (>95% purity; AnaSpec) 
in PBS and an equal volume of CFA containing 1 mg Mycobacterium tubercu-
losis H37Ra (Difco Laboratories) by s.c. inoculation at four flank sites. 200 ng 
pertussis toxin (List Biological Laboratories Inc.) was administered in 0.2 ml 
PBS i.v. on the day of immunization and 48 h later. Mice were weighed and 
assessed for clinical symptoms daily with the following scoring system: 0, no 
clinical signs; 1, limp tail; 2, paraparesis (weakness, incomplete paralysis of one 
or two hind limbs); 3, paraplegia (complete paralysis of two hind limbs);   
4, paraplegia with fore limb weakness or paralysis; and 5, moribund or dead.
Statistical analysis. Two-tailed unpaired Student’s t tests were used to analyze 
differences in mean values between groups. All data are presented as mean ± 
SEM. Differences with values of P < 0.05 were considered significant.
were captured using a mouse IFN- secretion assay (Miltenyi Biotec) as pre-
viously described (Pewe et al., 2004). IFN-–expressing CD4 T cells were 
sorted with a FACSDiva (BD). RNA was isolated using an RNeasy Mini kit 
(Invitrogen) and used for cDNA synthesis. V8-specific PCR products were 
synthesized because V8 is the most commonly used V element in the 
M133-specific response (Haring et al., 2001). PCR products were cloned 
into plasmid vector pCR2.1-TOPO (Invitrogen) and sequenced.
TCR Rg mice were engineered as previously described (Holst et al., 
2006). An M133-specific TCR- (V8.3, TRBV13-1) identified in three   
of three mice was produced synthetically (Geneart) and then cloned into a 
retroviral vector containing an IRES-GFP cassette to allow identification of 
transfected cells by GFP expression. Retroviral producer cell lines expressing 
this TCR- were produced and used to transduce B6 donor bone marrow 
before reconstitution of lethally irradiated B6 recipient mice. After reconsti-
tution, these Rg mice were infected with rJ2.2. The majority of CD4 T cells 
in the infected CNS were GFP+. I-Ab/M133 tetramer+ GFP+ cells were 
sorted from the infected CNS and analyzed for TCR- chain expression. 
Two TCR- chains (V2.3 and TRAV14-1), differing by a single amino acid 
in the CDR3 region, were detected using RT-PCR–based cloning. One of 
these TCR- was synthesized and cloned into the same retroviral vector de-
scribed in this section. In this vector, the TCR- and TCR- chains are 
linked via the 2A protease, facilitating cleavage. Because the two chains are 
linked on the same molecule, they are produced in stoichiometric amounts. 
TCR Rg mice expressing both M133-specific TCR- and TCR- were 
produced. Epitope M133 specificity was confirmed by analysis of GFP+ cells 
in the infected CNS using M133-specific tetramer and IFN- expression   
after peptide stimulation.
Viruses and infection. A recombinant rJ2.2 in which the M133 epitope 
was mutated to abolish binding to the I-Ab antigen (rJ2.2.MY135Q) was con-
structed as described previously (Anghelina et al., 2006). rJ2.2 and rJ2.2.MY135Q 
were propagated in mouse 17Cl-1 cells and titered on HeLa-MHVR cells 
(Pewe et al., 2005). 6–7-wk-old WT B6 and Foxp3gfp mice were inoculated 
intracerebrally with 600 PFU rJ2.2 or 2,000 PFU rJ2.2.MY135Q in 30 µl DME.
Antibodies. The following antibodies were used in this study: CD4-FITC, -PE, 
or -PerCP-Cy5.5 (RM 4–5), CD69-PE (H1.2F3), IL-2-PE (JES6-5H4; BD); 
purified functional anti-CD3, CD3-PerCP-Cy5.5 (145-2C11), CD4–Alexa 
Fluor 700 (RM 4–5), CD16/CD32-biotin or -PerCP-Cy5.5 (93), Foxp3-
FITC, -PE, or –Alexa Fluor 647 (FJK-16s), T-bet–PE (eBio4B10), IFN-–PE 
or –allophycocyanin (APC; XMG1.2), TNF-PE (MP6-XT22), CTLA-4–PE 
(UC10-4B9),  ICOS-PE  (7E.17G9),  eFluor  450–conjugated  anti-CD11b 
(M1/70),  CD11c  (N418),  F4/80  (BM8),  B220  (RA3-6B2),  and  CD49b 
(DX5) mAbs (eBioscience); and IL-10-APC (JES5-16E3) and Helios-PE 
(22F6; BioLegend).
Isolation of mononuclear cells from CNS tissue. Brains and spinal 
cords harvested after PBS perfusion were dispersed and digested with 1 mg/ml 
collagenase D (Roche) and 0.1 mg/ml DNase I (Roche) at 37°C for 30 min. 
Dissociated CNS tissue was passed through a 70-µm cell strainer, followed by 
Percoll gradient (70/37%) centrifugation. Mononuclear cells were collected from 
the interphase, washed, and resuspended in culture medium for further analysis.
MHC class II tetramer staining. CNS-derived mononuclear cells were 
stained with 8 µg/ml PE-conjugated I-Ab/M133 tetramers (obtained from 
the National Institutes of Health/National Institute of Allergy and Infectious 
Diseases MHC Tetramer Core Facility, Atlanta, GA) in RP10 media for 1 h 
at 37°C. Cells were then incubated with anti–CD16/CD32-biotin and anti–
CD4-PerCP-Cy5.5, followed by Avidin-APC. Cells were analyzed using a 
FACSCalibur  (BD).  Results  are  shown  after  gating  on  CD16/CD32- 
negative cell populations.
Measurement of BrdU incorporation. Foxp3gfp mice were injected i.p. 
with 2 mg BrdU (BD) at 6 d after infection. BrdU incorporation by brain 
CD4 T cells was examined 16 h after injection according to manufacturer 
protocols (APC BrdU flow kit; BD).JEM Vol. 208, No. 8  1577
Brief Definitive Report
Lund, J.M., L. Hsing, T.T. Pham, and A.Y. Rudensky. 2008. Coordination of 
early protective immunity to viral infection by regulatory T cells. Science. 
320:1220–1224. doi:10.1126/science.1155209
Moon,  J.J.,  H.H.  Chu,  J.  Hataye, A.J.  Pagán,  M.  Pepper,  J.B.  McLachlan,   
T. Zell, and M.K. Jenkins. 2009. Tracking epitope-specific T cells. Nat. 
Protoc. 4:565–581. doi:10.1038/nprot.2009.9
Oldenhove, G., N. Bouladoux, E.A. Wohlfert, J.A. Hall, D. Chou, L. Dos Santos,   
S. O’Brien, R. Blank, E. Lamb, S. Natarajan, et al. 2009. Decrease of Foxp3+ 
Treg cell number and acquisition of effector cell phenotype during lethal 
infection. Immunity. 31:772–786. doi:10.1016/j.immuni.2009.10.001
Pewe, L.L., J.M. Netland, S.B. Heard, and S. Perlman. 2004. Very diverse CD8 
T cell clonotypic responses after virus infections. J. Immunol. 172:3151–3156.
Pewe, L., H. Zhou, J. Netland, C. Tangudu, H. Olivares, L. Shi, D. Look, T. 
Gallagher, and S. Perlman. 2005. A severe acute respiratory syndrome-
associated coronavirus-specific protein enhances virulence of an atten-
uated murine coronavirus. J. Virol. 79:11335–11342. doi:10.1128/JVI 
.79.17.11335-11342.2005
Sabatino, J.J. Jr., J. Huang, C. Zhu, and B.D. Evavold. 2011. High preva-
lence  of  low  affinity  peptide–MHC  II  tetramer–negative  effectors 
during  polyclonal  CD4+ T  cell  responses.  J.  Exp.  Med.  208:81–90. 
doi:10.1084/jem.20101574
Shafiani,  S.,  G. Tucker-Heard, A.  Kariyone,  K. Takatsu,  and  K.B.  Urdahl. 
2010. Pathogen-specific regulatory T cells delay the arrival of effector   
T cells in the lung during early tuberculosis. J. Exp. Med. 207:1409–1420. 
doi:10.1084/jem.20091885
Suffia,  I.J.,  S.K.  Reckling,  C.A.  Piccirillo,  R.S.  Goldszmid,  and Y.  Belkaid.   
2006. Infected site-restricted Foxp3+ natural regulatory T cells are spe-
cific  for  microbial  antigens.  J.  Exp.  Med.  203:777–788.  doi:10.1084/ 
jem.20052056
Tang, Q., K.J. Henriksen, M. Bi, E.B. Finger, G. Szot, J. Ye, E.L. Masteller, H. 
McDevitt, M. Bonyhadi, and J.A. Bluestone. 2004. In vitro–expanded 
antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. 
Med. 199:1455–1465. doi:10.1084/jem.20040139
Tarbell, K.V., S. Yamazaki, K. Olson, P. Toy, and R.M. Steinman. 2004. CD25+ 
CD4+ T cells, expanded with dendritic cells presenting a single auto-
antigenic peptide, suppress autoimmune diabetes. J. Exp. Med. 199:1467–
1477. doi:10.1084/jem.20040180
Thornton,  A.M.,  P.E.  Korty,  D.Q.  Tran,  E.A.  Wohlfert,  P.E.  Murray, 
Y. Belkaid, and E.M. Shevach. 2010. Expression of Helios, an Ikaros 
transcription factor family member, differentiates thymic-derived from 
peripherally induced Foxp3+ T regulatory cells. J. Immunol. 184:3433–
3441. doi:10.4049/jimmunol.0904028
Trandem, K., D. Anghelina, J. Zhao, and S. Perlman. 2010. Regulatory T cells 
inhibit  T cell proliferation and decrease demyelination in mice chronically 
infected with a coronavirus. J. Immunol. 184:4391–4400. doi:10.4049/ 
jimmunol.0903918
Vignali, D.A., L.W. Collison, and C.J. Workman. 2008. How regulatory T cells 
work. Nat. Rev. Immunol. 8:523–532. doi:10.1038/nri2343
Wang, Z., J. Hong, W. Sun, G. Xu, N. Li, X. Chen, A. Liu, L. Xu, B. Sun, and J.Z. 
Zhang. 2006. Role of IFN-gamma in induction of Foxp3 and conversion of 
CD4+ CD25- T cells to CD4+ Tregs. J. Clin. Invest. 116:2434–2441.
Xue, S., and S. Perlman. 1997. Antigen specificity of CD4 T cell response in 
the central nervous system of mice infected with mouse hepatitis virus. 
Virology. 238:68–78. doi:10.1006/viro.1997.8819
Zhao, J., J. Zhao, and S. Perlman. 2009. De novo recruitment of antigen- 
experienced and naive T cells contributes to the long-term maintenance 
of antiviral T cell populations in the persistently infected central nervous 
system. J. Immunol. 183:5163–5170. doi:10.4049/jimmunol.0902164
Online  supplemental  material.  Fig.  S1  shows  T-bet  expression  by 
rJ2.2-specific T reg cells. Fig. S2 shows IFN- expression by virus-specific 
T reg cells in the brains of infected B6 mice. Fig. S3 shows expression of 
activation markers and IL-10 by T reg cells derived from naive spleens and 
rJ2.2-infected brains. Fig. S4 shows helios expression by IFN-–expressing   
virus-specific T reg cells in the brains of infected B6 mice. Fig. S5 shows IL-10 
and IL-17 expression by MOG35-55-specific T reg cells in the CNS of mice 
with  EAE.  Online  supplemental  material  is  available  at  http://www.jem 
.org/cgi/content/full/jem.20110236/DC1.
We thank Drs. John Harty, Steven Varga, and Jonathan Trujillo for stimulating 
discussion and critical review of the manuscript, the National Institutes of Health 
(NIH)/National Institute of Allergy and Infectious Diseases Tetramer Core Facility 
(Atlanta, GA) for providing tetramers, Dr. D. Vignali (St. Jude’s Research Hospital) 
for reagents and guidance as we developed M133-specific TCR Rg mice, and the 
University of Iowa Flow Cytometry facility for help with cell sorting and analysis.
This work was supported in part by grants from the NIH (NS36592) and 
National Multiple Sclerosis Society. K.T. was supported by an NIH training grant (T32 
AI007511-14).
The authors declare no competing financial interests.
Submitted: 31 January 2011
Accepted: 20 June 2011
REFERENCES
Anghelina, D., L. Pewe, and S. Perlman. 2006. Pathogenic role for virus-specific 
CD4 T cells in mice with coronavirus-induced acute encephalitis. Am.   
J. Pathol. 169:209–222. doi:10.2353/ajpath.2006.051308
Belkaid, Y. 2007. Regulatory T cells and infection: a dangerous necessity. Nat. 
Rev. Immunol. 7:875–888. doi:10.1038/nri2189
Bergmann, C.C., T.E. Lane, and S.A. Stohlman. 2006. Coronavirus infection 
of the central nervous system: host-virus stand-off. Nat. Rev. Microbiol. 
4:121–132. doi:10.1038/nrmicro1343
Fleming, J.O., M.D. Trousdale, F.A. el-Zaatari, S.A. Stohlman, and L.P. Weiner. 
1986. Pathogenicity of antigenic variants of murine coronavirus JHM 
selected with monoclonal antibodies. J. Virol. 58:869–875.
Haring, J.S., L.L. Pewe, and S. Perlman. 2001. High-magnitude, virus-specific 
CD4  T-cell response in the central nervous system of coronavirus-infected 
mice. J. Virol. 75:3043–3047. doi:10.1128/JVI.75.6.3043-3047.2001
Holst, J., A.L. Szymczak-Workman, K.M.  Vignali, A.R. Burton, C.J. Workman, 
and D.A. Vignali. 2006. Generation of T-cell receptor retrogenic mice. 
Nat. Protoc. 1:406–417. doi:10.1038/nprot.2006.61
Koch, M.A., G. Tucker-Heard, N.R. Perdue, J.R. Killebrew, K.B. Urdahl, and 
D.J. Campbell. 2009. The transcription factor T-bet controls regulatory   
T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 
10:595–602. doi:10.1038/ni.1731
Lanteri, M.C., K.M. O’Brien, W.E. Purtha, M.J. Cameron, J.M. Lund, R.E. 
Owen, J.W. Heitman, B. Custer, D.F. Hirschkorn, L.H. Tobler, et al. 2009. 
Tregs control the development of symptomatic West Nile virus infection 
in humans and mice. J. Clin. Invest. 119:3266–3277.
Liu, F., and J.L. Whitton. 2005. Cutting edge: re-evaluating the in vivo cyto-
kine responses of CD8+ T cells during primary and secondary viral in-
fections. J. Immunol. 174:5936–5940.
Lühn, K., C.P. Simmons, E. Moran, N.T. Dung, T.N. Chau, N.T. Quyen, T.T. 
Thao, T. Van Ngoc, N.M. Dung, B. Wills, et al. 2007. Increased frequen-
cies  of  CD4+CD25high  regulatory T  cells  in  acute  dengue  infection.   
J. Exp. Med. 204:979–985. doi:10.1084/jem.20061381